Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway
Xinjun Zhao,1,2,* Yue Hua,1,2,* Hongmei Chen,1,2,* Haiyu Yang,3,* Tao Zhang,1,2,* Guiqiong Huang,4,* Huijie Fan,1,2 Zhangbin Tan,1,2 Xiaofang Huang,1,2 Bin Liu,5 Yingchun Zhou1,21The Key Laboratory of Molecular Biology, State Administration of Traditional Chinese Medicine, School of Traditional Chin...
Main Authors: | Zhao XJ, Hua Y, Chen HM, Yang HY, Zhang T, Huang GQ, Fan HJ, Tan ZB, Huang XF, Liu B, Zhou YC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-09-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | https://www.dovepress.com/aldehyde-dehydrogenase-2-protects-against-myocardial-infarction-relate-peer-reviewed-article-TCRM |
Similar Items
-
Association of Aldehyde Dehydrogenase 2 Gene Polymorphism with Myocardial Infarction
by: Zhu LP, et al.
Published: (2021-07-01) -
Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway
by: Jing Liu, et al.
Published: (2021-09-01) -
Association of functional variant of aldehyde dehydrogenase 2 with acute myocardial infarction of Chinese patients
by: Chen, R., et al.
Published: (2022) -
Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis
by: Yuanyuan Guo, et al.
Published: (2017-10-01) -
Aberrant Hypermethylation of Aldehyde Dehydrogenase 2 Promoter Upstream Sequence in Rats with Experimental Myocardial Infarction
by: Peng Wang, et al.
Published: (2015-01-01)